Advances in Targeting ACE2 for Developing COVID-19 Therapeutics

Since the onset of the coronavirus pandemic in December 2019, the SARS-CoV-2 virus has accounted for over 6.3 million lives resulting in the demand to develop novel therapeutic approaches to target and treat SARS-CoV-2. Improved understanding of viral entry and infection mechanisms has led to identi...

Descripción completa

Detalles Bibliográficos
Autores principales: Suvarnapathaki, Sanika, Chauhan, Divya, Nguyen, Angelina, Ramalingam, Murugan, Camci-Unal, Gulden
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581451/
https://www.ncbi.nlm.nih.gov/pubmed/36261668
http://dx.doi.org/10.1007/s10439-022-03094-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581451/
https://www.ncbi.nlm.nih.gov/pubmed/36261668
http://dx.doi.org/10.1007/s10439-022-03094-w

Ejemplares similares